T. Rowe Price Associates’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,342,927
Closed -$20.3M 2571
2020
Q1
$20.3M Buy
5,342,927
+352,137
+7% +$1.52M ﹤0.01% 1073
2019
Q4
$25.4M Buy
4,990,790
+137,498
+3% +$727K ﹤0.01% 1116
2019
Q3
$24.5M Buy
4,853,292
+3,701,740
+321% +$18.5M ﹤0.01% 1092
2019
Q2
$7.11M Buy
1,151,552
+980,574
+574% +$4.73M ﹤0.01% 1360
2019
Q1
$793K Buy
170,978
+400
+0.2% +$1.81K ﹤0.01% 1937
2018
Q4
$716K Buy
170,578
+120,869
+243% +$615K ﹤0.01% 1942
2018
Q3
$312K Sell
49,709
-546
-1% -$4.19K ﹤0.01% 2345
2018
Q2
$404K Sell
50,255
-30,723
-38% -$235K ﹤0.01% 2239
2018
Q1
$604K Sell
80,978
-30,362
-27% -$202K ﹤0.01% 2011
2017
Q4
$662K Buy
111,340
+81,240
+270% +$494K ﹤0.01% 1978
2017
Q3
$222K Hold
30,100
﹤0.01% 2380
2017
Q2
$204K Buy
30,100
+7,500
+33% +$55.4K ﹤0.01% 2376
2017
Q1
$213K Hold
22,600
﹤0.01% 2378
2016
Q4
$195K Hold
22,600
﹤0.01% 2388
2016
Q3
$143K Sell
22,600
-65,800
-74% -$398K ﹤0.01% 2396
2016
Q2
$373K Buy
88,400
+16,500
+23% +$79.7K ﹤0.01% 2085
2016
Q1
$313K Buy
71,900
+18,700
+35% +$83.3K ﹤0.01% 2141
2015
Q4
$326K Buy
53,200
+5,700
+12% +$37.4K ﹤0.01% 2120
2015
Q3
$272K Buy
47,500
+8,100
+21% +$62.2K ﹤0.01% 2178
2015
Q2
$294K Hold
39,400
﹤0.01% 2205
2015
Q1
$236K Hold
39,400
﹤0.01% 2290
2014
Q4
$298K Sell
39,400
-16,800
-30% -$101K ﹤0.01% 2179
2014
Q3
$292K Buy
56,200
+15,100
+37% +$75.2K ﹤0.01% 2161
2014
Q2
$177K Hold
41,100
﹤0.01% 2379
2014
Q1
$168K Hold
41,100
﹤0.01% 2364
2013
Q4
$219K Hold
41,100
﹤0.01% 2283
2013
Q3
$207K Hold
41,100
﹤0.01% 2257
2013
Q2
$183K Buy
+41,100
New +$184K ﹤0.01% 2233

Other funds holding PGNX